BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36525320)

  • 1. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type on the Dorsal Foot in a Senior Woman: A Case Report.
    Kelly J; Mirkin G; Yim J; Hao X
    J Am Podiatr Med Assoc; 2022; 112(6):. PubMed ID: 36525320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indurated Plaques on the Legs: Think Lymphoma.
    Watts-Santos A; Cuellar-Barboza A; Ramos-Cavazos CJ; Villarreal-Martinez A; Ocampo-Candiani J; Herz-Ruelas ME
    Acta Dermatovenerol Croat; 2021 Jul; 29(2):114-115. PubMed ID: 34477080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes in primary cutaneous diffuse large B-cell lymphoma, leg type.
    Kraft RM; Ansell SM; Villasboas JC; Bennani NN; Wang Y; Habermann TM; Thanarajasingam G; Lester SC; Macon W; Inwards DJ; Porrata LF; Micallef IN; Witzig TE; Thompson CA; Johnston PB; Nowakowski GS; Lin Y; Paludo J
    Hematol Oncol; 2021 Dec; 39(5):658-663. PubMed ID: 34453851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous regression of primary cutaneous diffuse large B-cell lymphoma, leg type with significant T-cell immune response.
    Graham PM; Richardson AS; Schapiro BL; Saunders MD; Stewart DM
    JAAD Case Rep; 2018 May; 4(4):305-309. PubMed ID: 29693055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type, With Spontaneous Regression After Biopsy.
    Marrero-Alemán G; Montenegro-Dámaso T; Peñate Y
    Am J Dermatopathol; 2017 Oct; 39(10):785-787. PubMed ID: 28926365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.
    Jia J; Li W; Zheng Y
    Medicine (Baltimore); 2017 Feb; 96(8):e6161. PubMed ID: 28225499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical clinicopathologic presentation of primary cutaneous diffuse large B-cell lymphoma, leg type.
    Massone C; Fink-Puches R; Wolf I; Zalaudek I; Cerroni L
    J Am Acad Dermatol; 2015 Jun; 72(6):1016-20. PubMed ID: 25824272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone involvement in primary cutaneous diffuse large B-cell lymphoma, leg-type.
    Laurent C; Ram-Wolff C; Ingen-Housz-Oro S; Beylot-Barry M; Barete S; Saillard C; Dupuy A; Bagot M; Adamski H
    Clin Exp Dermatol; 2023 Feb; 48(2):116-120. PubMed ID: 36730524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [An atypical presentation of primary cutaneous diffuse B-cell lymphoma, leg type].
    Brouillard C; Granel-Brocard F; Montagne K; Bastien C; Barbaud A; Schmutz JL
    Ann Dermatol Venereol; 2011; 138(8-9):601-4. PubMed ID: 21893235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous diffuse large B-cell lymphoma (PCDLBCL), leg-type and other: an update on morphology and treatment.
    Paulli M; Lucioni M; Maffi A; Croci GA; Nicola M; Berti E
    G Ital Dermatol Venereol; 2012 Dec; 147(6):589-602. PubMed ID: 23149705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary diffuse large B-cell lymphoma of the cranial vault with Trousseau syndrome: a case report.
    Uchida T; Amagasaki K; Hosono A; Nakaguchi H
    J Med Case Rep; 2021 Aug; 15(1):431. PubMed ID: 34404459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary cutaneous large B-cell lymphoma of scalp: Case report of a rare variant.
    Khatib Y; Dande M; Patel RD; Makhija M
    Indian J Pathol Microbiol; 2017; 60(2):268-271. PubMed ID: 28631652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical course of immunotactoid glomerulopathy complicated with diffuse large B-cell lymphoma.
    Takahashi H; Sano T; Kawamura S; Sano K; Miyasaka R; Yamazaki T; Sakakibara M; Abe T; Hashimoto K; Nagaoka M; Kamata M; Naito S; Aoyama T; Moriya R; Takeuchi Y
    CEN Case Rep; 2022 May; 11(2):184-190. PubMed ID: 34569002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of a primary cutaneous diffuse large B-cell lymphoma, leg type.
    Marasca C; Fabbrocini G; Cinelli E; Fontanella G; Marasca D; Zagaria O
    Int Wound J; 2020 Apr; 17(2):514-515. PubMed ID: 31884690
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffuse large B-cell lymphoma presenting as a chronic leg ulcer: the importance of repeat tissue biopsy.
    Khan JA; Usman F; Abbasi S; Shoab SS
    Ann R Coll Surg Engl; 2011 May; 93(4):e9-10. PubMed ID: 21944785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germinal Centre-Related Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type: Report of a Remission Case.
    Liu F; Qi F; Zhang X; Cao M; Peng S
    Clin Cosmet Investig Dermatol; 2022; 15():1265-1269. PubMed ID: 35821763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary cutaneous Epstein-Barr virus-associated diffuse large B-cell lymphoma in a patient with angioimmunoblastic T-cell lymphoma: a case report and review of literature.
    Yang QX; Pei XJ; Tian XY; Li Y; Li Z
    Diagn Pathol; 2012 Jan; 7():7. PubMed ID: 22260632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles.
    Cunningham D; Hawkes EA; Jack A; Qian W; Smith P; Mouncey P; Pocock C; Ardeshna KM; Radford JA; McMillan A; Davies J; Turner D; Kruger A; Johnson P; Gambell J; Linch D
    Lancet; 2013 May; 381(9880):1817-26. PubMed ID: 23615461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.